#LCSM Chat Topic 6-May-2021: The Hows and Whys of Cancer Research Advocacy
Cancer patient advocates first appeared decades ago, in the breast cancer community. Patient advocates are dedicated to supporting patients and their loved ones, improving lung cancer education and awareness, and generating funds for advocacy and research. With the advent of targeted therapies and immunotherapies for many types of cancer, the past ten years have seen a growing group of patients, survivors, and caregivers who have lived with cancer long enough to become active, knowledgeable advocates for their cancer community. There is another type of cancer patient advocate called a “research advocate.” Research… Read More
#LCSM Chat Topic 6/4/2020: #ASCO20 Roundup for #LungCancer
Please join #LCSM Chat Thursday, June 4, 2020, at 8 pm Eastern time (5 pm Pacific) to discuss the ASCO 2020 Annual Virtual Meeting presentations related to lung cancer. Usually, the ASCO Annual Meeting is held in Chicago, Illinois at the end of May/beginning of June, and attracts over 40,000 attendees from around the world. Due to social distancing recommended during the COVID-19 pandemic, ASCO 2020 is being conducted virtually this year. The scientific program happened May 29-31, and the educational program will happen August 8-10. The meeting was FREE to ASCO… Read More
#LCSM Chat Topic 4/2/2020: #COVID19 and #LungCancer
It seems that the world has turned upside down. At the time I write this, there have been almost 550,00 cases of COVID-19 confirmed in the world and over 85,000 in the US. Here in New York City there have been over 23,000 cases and 365 deaths as of March 27th (https://coronavirus.jhu.edu/map.html). The pandemic has placed enormous stress on our health care delivery system. For lung cancer patients, it has affected healthcare providers’ ability to perform tests and radiologic procedures; provide timely diagnosis, staging, and care for early stage patients; and, in… Read More
You must be logged in to post a comment.